CLINICAL_TRIALS
trial_result
· 2015-03-10
Clinical Trial Update: Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer [Phase 2]
Summary
Phase 2 trial evaluating NOV-002 with carboplatin in chemotherapy-resistant ovarian cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cellectar Biosciences, Inc. | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-03-10